Washington Research Foundation (WRF) has awarded $6 million in grant funding through a new program designed to support late-stage preclinical development and first-in-human clinical trials of novel ...

While there have been exciting advancements in the treatment of B-cell acute lymphoblastic leukemia over the course of the past decade, the treatment of older adults remains a challenge.

A research team, affiliated with UNIST has developed nanoparticles that effectively treat acute myeloid leukemia (AML), ...

The once-powerful producer convicted of rape has been diagnosed with a type of bone marrow cancer, according to multiple ...

PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today ...

AvenCell Therapeutics on Tuesday said it collected $112 million to continue clinical studies of two experimental acute ...

AvenCell Therapeutics has secured $112 million in series B funds as the Novo Holdings-backed biotech seeks clinical proof ...

Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer ...

This combination rapidly induces apoptosis in leukemia cells while sparing healthy cells ... no corporate or ideological interests. We don't put up a paywall – we believe in free access to information ...

The agreement aims to strengthen the Kingdom’s position in advanced therapies, aligning with Saudi Vision 2030, which focuses ...